Tel: 1-631-504-6093
Email:
Awesome Features1111

Slide Title 2

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas pulvinar nibh purus, eget convallis erat efficitur eget.

Read More

Awesome Features1111

This is description for slide three1111

Read More

FDA Approves Neratinib for Extended Adjuvant Treatment of Breast Cancer

On July 17, 2017, the U.S. Food and Drug Administration approved neratinib (Nerlynx, Puma Biotechnology, Inc.) for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancerĀ to […]

Read More →